IRIS
CONIGLIARO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.617
AS - Asia 4.074
EU - Europa 2.859
SA - Sud America 508
AF - Africa 90
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 4
Totale 29.241
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.474
SG - Singapore 1.861
CN - Cina 891
IT - Italia 537
RU - Federazione Russa 493
HK - Hong Kong 432
BR - Brasile 430
VN - Vietnam 314
DE - Germania 307
IE - Irlanda 287
FR - Francia 276
UA - Ucraina 201
FI - Finlandia 189
GB - Regno Unito 186
JP - Giappone 117
CA - Canada 83
SE - Svezia 71
KR - Corea 70
NL - Olanda 69
IN - India 63
BD - Bangladesh 55
ID - Indonesia 55
PL - Polonia 51
AU - Australia 46
NZ - Nuova Zelanda 43
DK - Danimarca 37
TW - Taiwan 36
MX - Messico 35
ES - Italia 31
ZA - Sudafrica 31
AR - Argentina 29
BE - Belgio 29
AT - Austria 27
TR - Turchia 27
EG - Egitto 23
SA - Arabia Saudita 21
IR - Iran 19
UZ - Uzbekistan 17
EC - Ecuador 14
PK - Pakistan 13
IQ - Iraq 12
MA - Marocco 12
LV - Lettonia 11
CO - Colombia 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
RO - Romania 9
AZ - Azerbaigian 8
PH - Filippine 8
CH - Svizzera 7
MY - Malesia 7
CL - Cile 6
KZ - Kazakistan 6
TN - Tunisia 6
ET - Etiopia 5
HU - Ungheria 5
SI - Slovenia 5
SV - El Salvador 5
VE - Venezuela 5
BG - Bulgaria 4
JM - Giamaica 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
IL - Israele 3
KE - Kenya 3
PA - Panama 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
YE - Yemen 3
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
NI - Nicaragua 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CZ - Repubblica Ceca 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
Totale 29.228
Salva come PNG Salva come JPEG
Città #
Wilmington 5.506
Houston 4.797
Woodbridge 4.462
Singapore 985
Fairfield 634
Ashburn 542
Ann Arbor 528
Chandler 426
Hong Kong 420
San Jose 405
Dallas 396
Beijing 273
Seattle 266
Dublin 233
Cambridge 212
New York 212
Council Bluffs 191
Medford 177
Jacksonville 159
Santa Clara 154
Rome 152
The Dalles 144
Los Angeles 133
Helsinki 132
Ho Chi Minh City 112
Tokyo 88
Dearborn 87
Moscow 82
Lawrence 81
Lauterbourg 76
Buffalo 63
São Paulo 62
Zhengzhou 59
Hanoi 57
Redwood City 49
London 48
Tauranga 42
Munich 39
Orem 39
Toronto 38
San Diego 36
Jakarta 34
Copenhagen 33
Seoul 32
Milan 31
Shenzhen 31
Amsterdam 30
Boardman 30
Chengdu 30
Nuremberg 29
Nanjing 28
Chicago 27
Kraków 27
Menlo Park 27
Guangzhou 26
Phoenix 25
Stockholm 25
Brussels 24
Frankfurt am Main 24
Johannesburg 24
Redondo Beach 23
Shanghai 22
Taipei 22
Warsaw 22
North Bergen 21
Denver 20
Melbourne 20
Montreal 19
Chaozhou 18
Dong Ket 18
Suzhou 18
Chennai 17
Brooklyn 16
Mülheim 16
Jeddah 15
Boston 14
Palo Alto 14
Augusta 13
Haiphong 13
Norwalk 13
Atlanta 12
Bassano del Grappa 12
Hefei 12
Lappeenranta 12
Leawood 12
Mumbai 12
Rio de Janeiro 12
San Francisco 12
Tanta 12
Brasília 11
Kunming 11
Mexico City 11
Mountain View 11
Center 10
Chongqing 10
Cincinnati 10
Las Vegas 10
Manchester 10
Sydney 10
Ankara 9
Totale 23.709
Salva come PNG Salva come JPEG
Nome #
Challenges in the treatment of Rheumatoid Arthritis 848
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 554
Complement, infection, and autoimmunity 541
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 514
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 513
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 510
Autoantibodies in inflammatory arthritis 505
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 497
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 472
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 470
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 469
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 465
Characterization of the anticollagen antibody response in a new model of chronic polyarthritis. 462
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 455
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 454
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 453
The type I IFN system in rheumatoid arthritis 450
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 450
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. 450
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 446
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 444
Identifying the cells breaching self-tolerance in autoimmunity. 436
Seronegative autoimmune diseases 431
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 429
Lymph node IL-18 expression in adult-onset Still's disease. 428
Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. 427
Th17 Effector Cells Support B Cell Responses Outside of Germinal Centres 427
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 427
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 421
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 414
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 410
Insights on the role of physical activity in patients with rheumatoid arthritis 410
The interplay between inflammation and metabolism in rheumatoid arthritis 407
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate 402
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 392
Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation 385
Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. 373
Natural killer and b cells in patients with rheumatoid arthritis and psoriatic arthritis treated with etanercept 364
Histopathology of the skin in rheumatic diseases 364
The complex interplay between rheumatoid arthritis and atopy: Focus on anti-TNFα treatment 358
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 357
Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. 355
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 342
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 340
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 315
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. 313
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 313
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 293
Interaction between microbiome and host genetics in psoriatic arthritis 292
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 272
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 251
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 248
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 245
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 245
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 231
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 229
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 227
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 222
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 221
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 220
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 194
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 191
Severe lupus nephritis: an unexpected association with Fabry disease 187
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 177
Correspondence to ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga and Liew—gender discrepancies at annual EULAR congresses: towards the gap narrowing 170
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender 167
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 166
Validation of “Clinical Red Flags” for RA-ILD in an Italian cohort 165
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 164
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 161
COVID-19: disCOVering the role of complement system 161
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study 158
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 153
Gender equality in Rheumatology 153
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 150
Tackling the autoimmune side in Spondyloarthritis: a systematic review 142
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 131
Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE 126
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 125
The steroid-sparing effect of JAK inhibitors across multiple patient populations 116
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 112
Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjögren's Syndrome 109
Alteration of telomere length and mtDNA copy number in interstitial lung disease associated with rheumatoid arthritis 105
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 105
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 104
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 102
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 101
The effects of smoking, alcohol, and dietary habits on the progression and management of spondyloarthritis 99
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy 97
The rs11568820 Variant in the Promoter Region of Vitamin D Receptor Gene Is Associated with Clinical Remission in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors 91
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 87
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 81
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 80
Kinesiophobia as part of the psychological burden in Spondyloarthritis: a case-control study 79
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 77
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis 75
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations 73
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population 73
Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy 72
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 72
Totale 28.609
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.231
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 0 44
2021/2022856 37 82 75 58 29 50 40 48 46 66 94 231
2022/20231.156 106 98 40 138 103 250 101 89 116 22 65 28
2023/2024573 60 17 22 15 67 129 15 77 26 19 42 84
2024/20252.818 87 543 359 154 34 256 121 113 226 245 363 317
2025/20266.055 370 395 831 647 536 235 760 615 579 596 437 54
Totale 29.757